GLP-1 receptor agonists in adults with diabetes undergoing coronary artery bypass grafting: a scoping review

Protocol registration for a scoping review, conducted according to JBI methodology and reported in accordance with PRISMA-ScR, that will map the evidence on glucagon-like peptide-1 receptor agonists, including the dual GIP/GLP-1 receptor agonist tirzepatide, in adults with diabetes undergoing coronary artery bypass grafting. The primary focus is diabetes-related outcomes; perioperative clinical and safety outcomes are a secondary focus.